ID1 and breast carcinoma: Studies by our group and others have already reported that Id1 marks a chemoresistant breast cancer cell [7] in cancers such as hepatocarcinomas [21], and the Kif11 pathway has been targeted in the treatment of docetaxel-resistant TNBC cells [22].